Literature DB >> 25116099

Fc receptors as adaptive immunoreceptors.

Marc Daëron1.   

Abstract

Most biological activities of antibodies depend on their ability to engage Receptors for the Fc portion of immunoglobulins (FcRs) on a variety of cell types. As FcRs can trigger positive and negative signals, as these signals control several biological activities in individual cells, as FcRs are expressed by many cells of hematopoietic origin, mostly of the myeloid lineage, as these cells express various combinations of FcRs, and as FcR-expressing cells have different functional repertoires, antibodies can exert a wide spectrum of biological activities. Like B and T Cell Receptors (BCRs and TCRs), FcRs are bona fide immunoreceptors. Unlike BCRs and TCRs, however, FcRs are immunoreceptors with an adaptive specificity for antigen, with an adaptive affinity for antibodies, with an adaptive structure and with an adaptive signaling. They induce adaptive biological responses that depend on their tissue distribution and on FcR-expressing cells that are selected locally by antibodies. They critically determine health and disease. They are thus exquisitely adaptive therapeutic tools.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25116099      PMCID: PMC7120570          DOI: 10.1007/978-3-319-07911-0_7

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  152 in total

1.  Both FcgammaRIV and FcgammaRIII are essential receptors mediating type II and type III autoimmune responses via FcRgamma-LAT-dependent generation of C5a.

Authors:  Shahzad N Syed; Stephanie Konrad; Kristina Wiege; Bernhard Nieswandt; Falk Nimmerjahn; Reinhold E Schmidt; J Engelbert Gessner
Journal:  Eur J Immunol       Date:  2009-12       Impact factor: 5.532

2.  The engagement of activating FcgammaRs inhibits primate lentivirus replication in human macrophages.

Authors:  Annie David; Asier Sáez-Cirión; Pierre Versmisse; Odile Malbec; Bruno Iannascoli; Florence Herschke; Marianne Lucas; Françoise Barré-Sinoussi; Jean-François Mouscadet; Marc Daëron; Gianfranco Pancino
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

Review 3.  The high-affinity IgE receptor on eosinophils: from allergy to parasites or from parasites to allergy?

Authors:  A S Gounni; B Lamkhioued; E Delaporte; A Dubost; J P Kinet; A Capron; M Capron
Journal:  J Allergy Clin Immunol       Date:  1994-12       Impact factor: 10.793

4.  Theory of equilibrium binding of asymmetric bivalent haptens to cell surface antibody: application to histamine release from basophils.

Authors:  C Wofsy; B Goldstein; M Dembo
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

5.  The Src homology 2 domain-containing inositol 5-phosphatase negatively regulates Fcgamma receptor-mediated phagocytosis through immunoreceptor tyrosine-based activation motif-bearing phagocytic receptors.

Authors:  Koji Nakamura; Alexander Malykhin; K Mark Coggeshall
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

6.  Restoration of tolerance in lupus by targeted inhibitory receptor expression.

Authors:  Tracy L McGaha; Brian Sorrentino; Jeffrey V Ravetch
Journal:  Science       Date:  2005-01-28       Impact factor: 47.728

7.  Fcγ receptors inhibit mouse and human basophil activation.

Authors:  Lydie Cassard; Friederike Jönsson; Ségolène Arnaud; Marc Daëron
Journal:  J Immunol       Date:  2012-08-20       Impact factor: 5.422

8.  Salmonella escape from antigen presentation can be overcome by targeting bacteria to Fc gamma receptors on dendritic cells.

Authors:  Jaime A Tobar; Pablo A González; Alexis M Kalergis
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

9.  Immunocytochemical investigations on the presence of neuron-specific antibodies in the CSF of Parkinson's disease cases.

Authors:  A McRae-Degueurce; L Rosengren; K Haglid; S Bööj; C G Gottfries; A C Granérus; A Dahlström
Journal:  Neurochem Res       Date:  1988-07       Impact factor: 3.996

10.  T-independent antibody responses to T-dependent antigens: a novel follicular dendritic cell-dependent activity.

Authors:  Mohey Eldin M El Shikh; Rania M El Sayed; Andras K Szakal; John G Tew
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

View more
  18 in total

1.  Immunoglobulin G structure and rheumatoid factor epitopes.

Authors:  Sheila Lefoli Maibom-Thomsen; Nicole Hartwig Trier; Bettina Eide Holm; Kirsten Beth Hansen; Morten Ib Rasmussen; Anna Chailyan; Paolo Marcatili; Peter Højrup; Gunnar Houen
Journal:  PLoS One       Date:  2019-06-14       Impact factor: 3.240

Review 2.  Beyond binding: antibody effector functions in infectious diseases.

Authors:  Lenette L Lu; Todd J Suscovich; Sarah M Fortune; Galit Alter
Journal:  Nat Rev Immunol       Date:  2017-10-24       Impact factor: 53.106

3.  FcγRIIB mediates antigen-independent inhibition on human B lymphocytes through Btk and p38 MAPK.

Authors:  Shiang-Jong Tzeng; Wan-Yu Li; Hui-Ying Wang
Journal:  J Biomed Sci       Date:  2015-10-16       Impact factor: 8.410

4.  Immune Complex-Induced, Nitric Oxide-Mediated Vascular Endothelial Cell Death by Phagocytes Is Prevented with Decoy FcγReceptors.

Authors:  Ramanjaneya V R Mula; Deepa Machiah; Lauren Holland; Xinyu Wang; Harish Parihar; Avadhesh C Sharma; Periasamy Selvaraj; Rangaiah Shashidharamurthy
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

Review 5.  Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins.

Authors:  Liming Liu
Journal:  Protein Cell       Date:  2017-04-19       Impact factor: 14.870

Review 6.  Role of the adaptive immune system in atherosclerosis.

Authors:  Klaus Ley
Journal:  Biochem Soc Trans       Date:  2020-10-30       Impact factor: 4.919

Review 7.  How Mouse Macrophages Sense What Is Going On.

Authors:  Klaus Ley; Akula Bala Pramod; Michael Croft; Kodi S Ravichandran; Jenny P Ting
Journal:  Front Immunol       Date:  2016-06-02       Impact factor: 7.561

8.  Upregulation of FcγRIIB by resveratrol via NF-κB activation reduces B-cell numbers and ameliorates lupus.

Authors:  Jyun-Pei Jhou; Se-Jie Chen; Ho-Yin Huang; Wan-Wan Lin; Duen-Yi Huang; Shiang-Jong Tzeng
Journal:  Exp Mol Med       Date:  2017-09-29       Impact factor: 8.718

9.  FcεRI γ-Chain Negatively Modulates Dectin-1 Responses in Dendritic Cells.

Authors:  Yi-Gen Pan; Yen-Ling Yu; Chi-Chien Lin; Lewis L Lanier; Ching-Liang Chu
Journal:  Front Immunol       Date:  2017-10-27       Impact factor: 7.561

Review 10.  Harnessing the immune system via FcγR function in immune therapy: a pathway to next-gen mAbs.

Authors:  Alicia M Chenoweth; Bruce D Wines; Jessica C Anania; P Mark Hogarth
Journal:  Immunol Cell Biol       Date:  2020-04-12       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.